Selegiline slows the progression of the symptoms of Parkinson disease.
Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis.
The Effect of Deprenyl (Selegiline) on the Natural History of Parkinson's Disease
Transdermal selegiline in HIV-associated cognitive impairment: pilot, placebo-controlled study
Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: A 3‐month, randomized, placebo‐controll...
l‐(−)‐Desmethylselegiline, a Metabolite of Selegiline [l‐(−)‐Deprenyl], Protects Mesencephalic Dopamine Neurons from Excitotox...
Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the ...
Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline)
Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline
Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild ...